0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Gene Therapy for HIV and Chronic Infections (Hardcover, 2015 ed.) Loot Price: R3,433
Discovery Miles 34 330
You Save: R647 (16%)
Gene Therapy for HIV and Chronic Infections (Hardcover, 2015 ed.): Ben Berkhout, Hildegund C. J. Ertl, Marc S. Weinberg

Gene Therapy for HIV and Chronic Infections (Hardcover, 2015 ed.)

Ben Berkhout, Hildegund C. J. Ertl, Marc S. Weinberg

Series: American Society of Gene & Cell Therapy, 848

 (sign in to rate)
List price R4,080 Loot Price R3,433 Discovery Miles 34 330 | Repayment Terms: R322 pm x 12* You Save R647 (16%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: American Society of Gene & Cell Therapy, 848
Release date: March 2015
First published: 2015
Editors: Ben Berkhout • Hildegund C. J. Ertl • Marc S. Weinberg
Dimensions: 235 x 155 x 16mm (L x W x T)
Format: Hardcover - Cloth over boards
Pages: 236
Edition: 2015 ed.
ISBN-13: 978-1-4939-2431-8
Categories: Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Nursing & ancillary services > Specific disorders & therapies > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
Promotions
LSN: 1-4939-2431-1
Barcode: 9781493924318

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners